Blood marker may replace scopes for IBD monitoring
NCT ID NCT07621783
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a protein in the blood called LRG can accurately show how active Crohn's disease or ulcerative colitis is in the gut. Researchers will compare LRG levels with standard endoscopic and symptom scores in 100 European adults. If successful, LRG could become a simpler, less invasive way to monitor disease activity.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE (CD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Imelda General Hospital
RECRUITINGBonheiden, 2820, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a tree mushroom drink calm inflammatory bowel disease?
- Can pregnancy and neurological disease coexist safely? a new registry seeks answers
- A simple hospital checklist could flag hidden malnutrition in kids with IBD
- Could IBD medications during pregnancy shape a Child's development?
- Can AI learn to grade endoscopy quality from video?
- Can a new pill tame ulcerative colitis Flare-Ups?